TY  - BOOK
AU  - Schulthess,Gustav Konrad von
TI  - Molecular anatomic imaging: PETCT, PETMR, and SPECTCT 
SN  - 9781496319241
PY  - 2016///]
CY  - Philadelphia
PB  - Wolters Kluwer Health
KW  - Tomography, Emission
KW  - Radioisotope scanning
KW  - Tomography
KW  - Diagnostic imaging
KW  - Photography
KW  - Diagnosis
KW  - Single-photon emission computed tomography
KW  - Methodology
KW  - Tomography, Emission-Computed
KW  - Investigative Techniques
KW  - Image Interpretation, Computer-Assisted
KW  - Radionuclide Imaging
KW  - Image Enhancement
KW  - Analytical, Diagnostic and Therapeutic Techniques and Equipment
KW  - Diagnostic Imaging
KW  - Diagnostic Techniques, Radioisotope
KW  - Diagnostic Techniques and Procedures
KW  - Positron-Emission Tomography
KW  - Tomography, Emission-Computed, Single-Photon
KW  - Methods
N1  - pt. I BASIC ASPECTS OF HYBRID IMAGING TECHNOLOGY -- 1. Radiation Sources for Emission Scanning: Positron and Gamma Emission -- 2. PET Scanning: Principles and Instrumentation -- 3. SPECT Scanning: Principles and Technologic Options -- 4. Basics of CT Scanning and Issues Relevant to Hybrid Imaging -- 5. MR Scanning: Principles Relevant to Hybrid Imaging -- 6. Attenuation Correction for Emission Scanning -- 7. Options in Image Reconstruction in Hybrid Imaging -- 8. Image Coregistration and Coregistered Image Rendering -- 9. Quantifying PET and SPECT -- 10. Standardizing PET and SPECT for Quantitative Imaging -- 11. Minimizing Radiation Dose in Hybrid Imaging -- 12.A Primer in Compartment Modeling -- pt. II RADIOPHARMACEUTICALS -- 13. Clinical PET Radiopharmaceuticals Based on 18Fluorine -- 14. Clinical PET Radiopharmaceuticals Prepared from Cyclotron-Produced Positron Emitters Other Than Fluorine 18 -- 15. Clinical PET Radiopharmaceuticals Produced by Generators -- 16. Clinical SPECT Radiopharmaceuticals -- pt. III CLINICAL HYBRID IMAGING OF THE BRAIN -- 17. The Normal Brain Scan: Appearance and Data Analysis -- 18. Cerebrovascular Disease -- 19. Brain Tumors: Astrocytoma, Oligodendroglioma, and Glioblastoma -- 20. Brain Tumors: Other Primary Brain Tumors, Metastases, and Radiation Injury -- 21. Infections of the Central Nervous System -- 22. Epilepsy -- 23. Neurodegenerative Disease: Protocols, Normal Findings, and Pitfalls -- 24. Dementia; 25. Movement Disorders -- 26. Pediatric Hybrid Imaging of the Brain -- pt. IV CLINICAL MULTIMODALITY IMAGING OF THE HEART -- 27. Protocols, Data Analysis, Normal Scans, and Pitfalls in the Heart -- 28. Coronary Artery Disease: Perfusion -- 29. Coronary Artery Disease: Tissue Viability and Perfusion -- 30. Noncoronary Cardiac Disease -- pt. V CLINICAL HYBRID IMAGING IN BODY ONCOLOGY -- Section A PROTOCOLS, NORMAL FINDINGS, ARTIFACTS, AND PITFALLS -- 31. Artifacts in Hybrid Extended Region Scans -- 32. FDG Hybrid Imaging: Protocols, Normal Scans, and Pitfalls -- 33. Basics of Molecular Imaging of Prostate Cancer -- 34. Somatostatin Receptor SPECT and PET Imaging: Protocols, Normal Findings, Artifacts, and Pitfalls -- 35. Bone-Seeking Tracers: [99mTc]Diphosphonate SPECT/CT and [18F]Fluoride PET/CT -- 36. SPECT and PET Imaging of the Thyroid: Protocols, Dosimetry, Normal Findings, Artifacts, and Pitfalls -- 37. Sentinel Node SPECT/CT Imaging for Tumor Staging: Protocols, Normal Findings, Artifacts Pitfalls, and Clinical Applications -- Section B HEAD AND NECK TUMORS -- 38. Head and Neck Cancer -- 39. Tumors with an Unknown Primary (CUP) -- 40. Thyroid Cancer -- Section C TUMORS OF THE THORAX -- 41. Non-Small Cell Lung Cancer -- 42. Small Cell Lung Cancer -- 43. Malignant Pleural Mesothelioma -- 44. Mediastinal Tumors -- Section D TUMORS OF THE GASTROINTESTINAL TRACT -- 45. Esophageal and Gastric Cancers -- 46. Malignant Tumors of the Hepatobiliary Tract and Pancreas; 47. Gastrointestinal Stromal Tumors -- 48. Neuroendocrine Tumors -- 49. Colorectal and Anal Carcinoma -- Section E BREAST CANCER AND GENITOURINARY TUMORS -- 50. Carcinoma of the Breast -- 51. Renal Tumors and Bladder Cancer -- 52. Tumors of the Female Genital Tract -- 53. Testicular Cancer -- 54. Prostate Cancer -- Section F TUMORS OF BONE, JOINTS, MUSCLES, SKIN, AND CONNECTIVE TISSUE -- 55. Malignant Bone Tumors -- 56. Bone Metastases -- 57. Benign Bone Tumors -- 58. Soft Tissue Sarcomas -- 59. Melanoma -- Section G TUMORS OF THE LYMPHATIC AND HEMOPOIETIC SYSTEMS -- 60. Malignant Lymphoma -- 61. Multiple Myeloma -- Section H RADIATION THERAPY -- 62. Radiation Oncology: Staging, Follow-Up, and Planning -- 63. Physiologic Basis of Inflammation Imaging -- 64. Soft Tissue Inflammation Including Vessels and Grafts -- 65. Musculoskeletal Infections -- 66. Infections in Patients with Orthopedic Implants -- 67. Rheumatologic Disease -- 68. Trauma -- 69. Parathyroid and Benign Thyroid Disease -- 70. Pulmonary Thromboembolism -- pt. VII CLINICAL HYBRID IMAGING IN PEDIATRIC PATIENTS -- 71. Special Considerations in Pediatric Patients -- 72. Pediatric Whole-Body Oncology -- 73. Pediatric Inflammation and Other Nonneoplastic Diseases
N2  - This brand new book discusses the most relevant technique or combination thereof for each disease and provides guidance on which modality to use -It is a disease oriented reference meant for interpreting integrated imaging studies. While it focuses on PET-CT and SPECT-CT, it also integrates PET-MR were applicable. Features: Allows clinical hybrid imaging users to compare modalities and decide whether to use PET/CT, PET/MR or SPECT/CT to solve a clinical question. Focus on clinical applications sans technological & radiopharmaceutical details. Inclusion of emerging field of PET/MR. New PART III on workflow and normal scans with various clinical tracers. Only book that incorporates PET/MR in a systematic way
UR  - https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=1473184
ER  -